A Review of Treatments for Patients with Metastatic Melanoma..Jim Breitfeller

The educational objectives of this activity are:

1.)Describe existing standard treatments for metastatic melanoma

2.)Clarify the mechanisms of action of monoclonal antibodies

3.)Discuss recent clinical trial outcomes of Ipilimumab and Tremelimumab based treatments in metastatic melanoma

4.)Describe the side-effects of Ipilimumab and Tremelimumab as well as other treatments in patients with metastatic melanoma
Describe appropriate nursing management of patients receiving Ipilimumab and Tremelimumab

Disclosures of significant relationships for author and planning committee and sponsorship :

The author, Suzanne McGettigan, MSN, CRNP, is a speaker for the Amgen, Inc. speaker’s bureaus. Carolyn Vachani, MSN, AOCN and Margaret Hampshire, BSN, OCN (planning committee members) have no financial relationships to disclose. This activity is supported through an unrestricted educational grant from Bristol Myers Squibb.


Source:http://www.oncolink.org/resources/article.cfm?c=16&s=59&ss=224&id=972


A Review of Treatments for Patients with Metastatic Melanoma



Take care
Jimmy B